Le Lézard
Classified in: Science and technology, Business
Subjects: ACC, CXP

IQST - iQSTEL Announces $27M In Revenue for the Month of April; Company Could Surpass $250M in Revenue for FY 2024


NEW YORK, May 6, 2024 /PRNewswire/ -- iQSTEL Inc. (OTC-QX: IQST) (www.iQSTEL.com) a US-based, multinational, fully reporting and audited publicly listed telecommunications and technology company preparing for a Nasdaq up-listing today announced achieving $27 million in revenue for the month of April based on preliminary accounting. 

Management highlights that the April results indicate the company could exceed $250 million in revenue by year end FY2024.  While iQSTEL recently announced a strategic acquisition bringing the company's forward looking annualized revenue to over $250 million, achieving $250 million by year end FY2024 would surpass expectations.

The company's gross profit surpassed $600,000 in April.  The company achieved consistent operational profitability in Q3 last year.  Management anticipates the profitability trend to continue with the company posting close to $2 million in gross profit per quarter.

The company recently reported more than $50 Million revenue for Q1 FY2024, and now is reporting $27M just for the month of April alone.  Additionally, the Q2 gross profit per month is almost double the Q1 gross profit per month.

iQSTEL CEO Leandro Iglesias stated: "We are thrilled to be heading into the International Telecom Week (ITW) Conference in Washington DC having recently achieved status as a quarter billion dollar company.  We have started this fiscal year with skyrocketing growth.  We expect to have a notable Prescence at ITW.  I look forward to sharing our experience with you."

ITW (https://www.internationaltelecomsweek.com) is the world's largest summit for digital infrastructure executives. More than 7,000 people from 125 countries, many from the largest operators in the world, are expected to attend this year's conference in National Harbor, Maryland. The agenda offers a broad range of topic tracks for the telecoms industry, including Future Networks, Digital Divide, SatCom and Data Center.

About IQSTEL:

iQSTEL Inc. (OTC-QX: IQST) (www.iQSTEL.com) is a US-based, multinational publicly listed company preparing for a Nasdaq up-listing with an FY2023 $144 million revenue, and with a Quarter Billion Dollar Revenue forecast and a Positive Operating Income of 7 digits forecast for FY-2024. iQSTEL's mission is to serve basic human needs in today's modern world by making the necessary tools accessible regardless of race, ethnicity, religion, socioeconomic status, or identity.  iQSTEL recognizes that in today's modern world, the pursuit of the human hierarchy of needs (physiological, safety, relationship, esteem and self-actualization) is marginalized without access to ubiquitous communications, the freedom of virtual banking, clean affordable mobility and information and content. iQSTEL has 4 Business Divisions delivering accessibly to the necessary tools in today's pursuit of basic human needs: Telecommunications, Fintech, Electric Vehicles and Metaverse.

The company continues to grow and expand its suite of products and services both organically and through mergers and acquisitions.  iQSTEL has completed 10 acquisitions since June 2018 and continues to develop an active pipeline of potential future acquisitions.

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and iQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

iQSTEL Inc.
IR US Phone: 646-740-0907
IR Email: [email protected]

Contact Details
iQSTEL Inc.
+1 646-740-0907
[email protected]

Company Website
www.iqstel.com

Logo: https://mma.prnewswire.com/media/1308745/iQSTEL_Logo.jpg

SOURCE iQSTEL Inc.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: